Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4143

1.

Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.

Ferguson MW, O'Kane S.

Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):839-50. Review.

PMID:
15293811
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.

Occleston NL, Laverty HG, O'Kane S, Ferguson MW.

J Biomater Sci Polym Ed. 2008;19(8):1047-63. doi: 10.1163/156856208784909345. Review.

PMID:
18644230
[PubMed - indexed for MEDLINE]
3.

The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.

Lin RY, Adzick NS.

Semin Pediatr Surg. 1996 Aug;5(3):165-74.

PMID:
8858763
[PubMed - indexed for MEDLINE]
4.

Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair.

Adzick NS, Lorenz HP.

Ann Surg. 1994 Jul;220(1):10-8. Review.

PMID:
8024353
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation.

Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA.

J Am Coll Surg. 2005 Sep;201(3):391-7.

PMID:
16125072
[PubMed - indexed for MEDLINE]
6.

Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.

Shah M, Foreman DM, Ferguson MW.

J Cell Sci. 1994 May;107 ( Pt 5):1137-57.

PMID:
7929624
[PubMed - indexed for MEDLINE]
Free Article
7.

Novel therapies for scar reduction and regenerative healing of skin wounds.

Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG.

Trends Biotechnol. 2008 Apr;26(4):173-80. doi: 10.1016/j.tibtech.2007.12.007. Epub 2008 Mar 4. Review.

PMID:
18295916
[PubMed - indexed for MEDLINE]
8.

Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord.

Lagord C, Berry M, Logan A.

Mol Cell Neurosci. 2002 May;20(1):69-92.

PMID:
12056841
[PubMed - indexed for MEDLINE]
9.

[Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].

Liu W, Chua CH, Wu XL, Wang DR, Yin DM, Cui L, Cao YL, Longaker MT.

Zhonghua Yi Xue Za Zhi. 2003 Jan 10;83(1):31-6. Chinese.

PMID:
12757642
[PubMed - indexed for MEDLINE]
10.

Mammalian fetal organ regeneration.

Colwell AS, Longaker MT, Lorenz HP.

Adv Biochem Eng Biotechnol. 2005;93:83-100. Review.

PMID:
15791945
[PubMed - indexed for MEDLINE]
11.

Scarless integumentary wound healing in the mammalian fetus: molecular basis and therapeutic implications.

Kathju S, Gallo PH, Satish L.

Birth Defects Res C Embryo Today. 2012 Sep;96(3):223-36. doi: 10.1002/bdrc.21015. Review.

PMID:
23109318
[PubMed - indexed for MEDLINE]
12.

Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.

Shah M, Foreman DM, Ferguson MW.

J Cell Sci. 1995 Mar;108 ( Pt 3):985-1002.

PMID:
7542672
[PubMed - indexed for MEDLINE]
Free Article
13.

Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.

Cowin AJ, Holmes TM, Brosnan P, Ferguson MW.

Eur J Dermatol. 2001 Sep-Oct;11(5):424-31.

PMID:
11525949
[PubMed - indexed for MEDLINE]
14.

The effect of suramin on healing adult rodent dermal wounds.

Chamberlain J, Shah M, Ferguson MW.

J Anat. 1995 Feb;186 ( Pt 1):87-96.

PMID:
7649820
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model.

Mak K, Manji A, Gallant-Behm C, Wiebe C, Hart DA, Larjava H, Häkkinen L.

J Dermatol Sci. 2009 Dec;56(3):168-80. doi: 10.1016/j.jdermsci.2009.09.005. Epub 2009 Oct 24.

PMID:
19854029
[PubMed - indexed for MEDLINE]
16.

Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.

Occleston NL, Fairlamb D, Hutchison J, O'Kane S, Ferguson MW.

Expert Opin Investig Drugs. 2009 Aug;18(8):1231-9. doi: 10.1517/13543780903130594. Review.

PMID:
19604123
[PubMed - indexed for MEDLINE]
17.

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.

Ferguson MW, Duncan J, Bond J, Bush J, Durani P, So K, Taylor L, Chantrey J, Mason T, James G, Laverty H, Occleston NL, Sattar A, Ludlow A, O'Kane S.

Lancet. 2009 Apr 11;373(9671):1264-74. doi: 10.1016/S0140-6736(09)60322-6.

PMID:
19362676
[PubMed - indexed for MEDLINE]
18.

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.

Occleston NL, O'Kane S, Laverty HG, Cooper M, Fairlamb D, Mason T, Bush JA, Ferguson MW.

Wound Repair Regen. 2011 Sep;19 Suppl 1:s38-48. doi: 10.1111/j.1524-475X.2011.00711.x.

PMID:
21793965
[PubMed - indexed for MEDLINE]
19.

Three-dimensional hyaluronic acid grafts promote healing and reduce scar formation in skin incision wounds.

Hu M, Sabelman EE, Cao Y, Chang J, Hentz VR.

J Biomed Mater Res B Appl Biomater. 2003 Oct 15;67(1):586-92.

PMID:
14528455
[PubMed - indexed for MEDLINE]
20.

Bone morphogenetic protein-2 induces scar formation and skin maturation in the second trimester fetus.

Stelnicki EJ, Longaker MT, Holmes D, Vanderwall K, Harrison MR, Largman C, Hoffman WY.

Plast Reconstr Surg. 1998 Jan;101(1):12-9.

PMID:
9427911
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk